Jim Simons's position in Abbott Laboratories is currently worth $460 Million. That's 0.63% of their equity portfolio (16th largest holding). The first Abbott Laboratories trade was made in Q4 2013. Since then Jim Simons bought shares fourteen more times and sold shares on ten occasions. The investor's estimated purchase price is $527 Million, resulting in a loss of 13%.